Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-09-27
1996-10-22
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514561, 514912, A61K 31195, A61K 31205
Patent
active
055677312
ABSTRACT:
A composition for the inhibition of the abnormal postnatal axial growth of the eye of a maturing animal which comprises a pharmaceutically effective amount of a gamma aminobutyric acid antagonist relatively selective for GABA.sub.B receptors in the cells of the eye, said antagonist present in a carrier or diluent suitable for ocular administration. A suitable antagonist is 2-OH saclofen.
REFERENCES:
patent: 4865599 (1989-09-01), Chiou
patent: 5055302 (1991-10-01), Laties et al.
patent: 5122522 (1992-06-01), Laties et al.
patent: 5284843 (1994-02-01), Stone et al.
patent: 5356892 (1994-10-01), Laties et al.
patent: 5360801 (1994-11-01), Laties et al.
patent: 5385939 (1995-01-01), Laties et al.
Mosinger et al. Gaba-like Immunoreactivity in the Vertebrate Retina: A Species Comparison Exp. Eye Res. 1986 42:631-644.
Fiszer DePlazas et al. Light and Dark Adaptation Infulences Gaba Receptor Sites in the Chick Retina Neurochemical Res. 1986 11:973-981.
Ikeda et al. Actions of baclofen and phaclofen upon ON-- and OFF-- ganglion cells in the cat retina European J. Pharm. 1990 190:1.
Iuvone et al. Dopamine mediates the light-evoked suppression of serotonin N-acetyltransferase activity in retina Brain Research 1987 418:314-324.
The Merck Index, Tenth Edition, Martha Windholz, ed., 1983 772-773.
Society of Neuroscience Meeting, Abstract, Nov. 16-21, 1987 71.14:240.
Hoffmeister et al. Psychotropic Agents Part I Antipsychotics and Antidepressants, Zeelen F. Chemistry Structure and Activity Springer Verlag, New York 1980.
Stone et al. Muscarinic Antagonist Effects on Experimental Chick Myopia Exp. Eye Res. 1991 52:755-758.
Carter et al. Treating Blurred Vision Associated with Antipsychotic Medication Amer. Jour. Phychiatry 1977 134:941.
Meythaler et al. The Myopic and Miotic Effect of Pilocarpin and Glaucostat Albrecht v. Graefes Arch. Klin. Exp. Ophthal. 1971 181:234-245 published by.
Birdsall et al. Pirenzepine-a Ligant With Original Binding Properties to Muscarinic Receptors Scand. J. Gastro 1980 1-4.
Bedrossian R. The Effect of Atropine on Myopia Ophthalmology 1979 86:713-717.
Buckley et al. Antagonist Binding Properties of Five Cloned Muscarinic Receoptors Expressed in CHO K1 Cells Am. Soc. Pharm. Exp. Ther. 35:469-476 (1989).
Curtin The Myopias-Basic Science and Chemical Management Harper & Row 1985 220-225.
Goss D. A. Attempts to Reduce the Rate of Increase of Myopia in Young People-A Critical Literature Review Am. Jour. Ophth. & Physc. Optics 1982 59:828-841.
Hagan et al. The Relative Potencies of Cholinominetics and Muscarinic Antagonists on the Rat Iris in Vivo: Effects of pH on Potency of Pirenzepine and Telenzepine NS Arch Pharmacology 1988 338:476-483.
Hammer et al. Selective Muscarinic Receptor Antagonists TIPS Jun. 1982.
Heathcote et al. Pirenzepine Selectively Inhibits Gastric Acid Secretion: a Comparative Pharmacological Study Between Pirenzepine and Seven Antiacetylcholine Drugs Scand. J. Gastro 1980 15-23.
Jaup et al. Comparison of the Action of Pirenzepine and L-Hyoscyamine on Gastric Acid Secretion and Other Muscarinic Effects Scand. J. Gastro 1980 89-94.
Jaup et al. Cerebrospinal Fluid Concentration of Pirenzepine After Therapeutic Dosage Scand. J. Gastro. 1980 35-37.
Lambrecht et al. o-Methoyoxy-sila-hexocyclium: a New Quaternary M.sub.1 -Selective Muscarinic Antagonist Euro. Journ. Pharm. 1988 151:155-156.
Meriney et al. Cholinergic Innervation of the Smooth Muscle Cells in the Ceroid Coat of the Chick Eye and its Development J. Neuro. Sci. 1987 7:3827-3839.
Perr et al. Cyclic Nucleotides Regulate Collagen Production by Human Intestinal Smooth Muscle Cells Gastroenterology 1989 96:1521-1528.
Raviola et al. An Animal Model of Myopia N. E. Jour. Med. 1985 313:1162-1163.
Rubin et al. Myopia-A Treatable "Disease"? Survey of Ophthalmology 1976 21:65-69.
Scandinavian Journal of Gastroenterology Papers published ion 8 Jun. 1980 on Advances in Basic and Clinical Pharmacology of Pirenzepine.
Schudt C. The Affinity, Selectivity, and Biological Activity of Telenzepine Enantiomers Euro. Jour. Pharm. 1989 165:87-96.
Stone et al. Altered Retinal Amine Neurotransmitters in Form-Deprivation Myopia Soc. Neurosci. 1987 13:240.
Lin et al. Altered Dopamine Metabolism and Form-Derivation Myopia Invest. Ophth. Vis. Sci. 1988 29:33.
Taylor P. Pharmaceutical Basis of Therapeutics 1985 7th Ed. MacMillan Publ. Cholinergic Agonists Ch. 5, 100-108.
Francois et al. Ultrasonographic Study of the Effect of Different Miotics on the Eye Components Ophthalmologica, Basel 1977 175:328-338.
The Merck Index Eleventh Edition ed., Windholz 1989 80-780.
Laties Alan M.
Stone Richard A.
Fay Zohreh
The Trustees of the University of Pennsylvania
LandOfFree
Gaba-ergic modulation of eye growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gaba-ergic modulation of eye growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gaba-ergic modulation of eye growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358941